Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Chatelut

Showing results (61-70 of 77) with videos related to

Pageof 8
Sort By:
Cancer Chemotherapy and Pharmacology|June 15, 2000
Dihydropyrimidine dehydrogenase activity in normal, inflammatory and tumour tissues of colon and liver in humansR Guimbaud, S Guichard, C Dusseau, et al.
European Journal of Clinical Pharmacology|January 29, 1999
Relation between unbound plasma concentrations and toxicity in a prolonged oral etoposide scheduleN Perdaems, J M Bachaud, P Rouzaud, et al.
Cancer Chemotherapy and Pharmacology|March 11, 1999
A limited-sampling strategy for estimation of etoposide pharmacokinetics in cancer patientsB Tranchand, C Amsellem, E Chatelut, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 22, 2003
Pharmacokinetics of low-dose carboplatin and applicability of a method of calculation for estimating individual drug clearanceM C Etienne, F Leger, X Pivot, et al.
Cancer Chemotherapy and Pharmacology|June 15, 2007
Vinorelbine/docetaxel combination treatment of metastatic breast cancer: a phase I studyJ Bonneterre, M Campone, P Koralewski, et al.
Bulletin Du Cancer|March 1, 1994
[Concomitant association of radiotherapy and chemotherapy (CDDP 4-6 mg/m2/daily in continuous i.v. administration) in locally advanced ORL tumors]J M Bachaud, N Albin, C Gay, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 13, 2005
Selective inhibition of HER2 inhibits AKT signal transduction and prolongs disease-free survival in a micrometastasis model of ovarian carcinomaJ P Delord, C Allal, M Canal, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|July 21, 2018
Development and validation of an UHPLC-MS/MS method for simultaneous quantification of ibrutinib and its dihydrodiol-metabolite in human cerebrospinal fluidD Beauvais, J-F Goossens, E Boyle, et al.
Journal of Immunological Methods|July 27, 2007
Evaluation of a peptide ELISA for the detection of rituximab in serumH Blasco, G Lalmanach, E Godat, et al.
Cancer Chemotherapy and Pharmacology|December 29, 2000
Population pharmacokinetics of topotecan: intraindividual variability in total drugA Montazeri, M Boucaud, F Lokiec, et al.
Pageof 8

Showing results (61-70 of 77) with videos related to

Sort By:
Pageof 8
Cancer Chemotherapy and Pharmacology|June 15, 2000
Dihydropyrimidine dehydrogenase activity in normal, inflammatory and tumour tissues of colon and liver in humansR Guimbaud, S Guichard, C Dusseau, et al.
European Journal of Clinical Pharmacology|January 29, 1999
Relation between unbound plasma concentrations and toxicity in a prolonged oral etoposide scheduleN Perdaems, J M Bachaud, P Rouzaud, et al.
Cancer Chemotherapy and Pharmacology|March 11, 1999
A limited-sampling strategy for estimation of etoposide pharmacokinetics in cancer patientsB Tranchand, C Amsellem, E Chatelut, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 22, 2003
Pharmacokinetics of low-dose carboplatin and applicability of a method of calculation for estimating individual drug clearanceM C Etienne, F Leger, X Pivot, et al.
Cancer Chemotherapy and Pharmacology|June 15, 2007
Vinorelbine/docetaxel combination treatment of metastatic breast cancer: a phase I studyJ Bonneterre, M Campone, P Koralewski, et al.
Bulletin Du Cancer|March 1, 1994
[Concomitant association of radiotherapy and chemotherapy (CDDP 4-6 mg/m2/daily in continuous i.v. administration) in locally advanced ORL tumors]J M Bachaud, N Albin, C Gay, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 13, 2005
Selective inhibition of HER2 inhibits AKT signal transduction and prolongs disease-free survival in a micrometastasis model of ovarian carcinomaJ P Delord, C Allal, M Canal, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|July 21, 2018
Development and validation of an UHPLC-MS/MS method for simultaneous quantification of ibrutinib and its dihydrodiol-metabolite in human cerebrospinal fluidD Beauvais, J-F Goossens, E Boyle, et al.
Journal of Immunological Methods|July 27, 2007
Evaluation of a peptide ELISA for the detection of rituximab in serumH Blasco, G Lalmanach, E Godat, et al.
Cancer Chemotherapy and Pharmacology|December 29, 2000
Population pharmacokinetics of topotecan: intraindividual variability in total drugA Montazeri, M Boucaud, F Lokiec, et al.
Pageof 8